- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.
This conference is intended to expose physicians to subspecialized case studies as applied to research-based-outcomes, new technologies, and treatment concepts. Each week a new topic is presented and discussed—allowing for questions and new learning developments, and conceptual enrichment.
- Radiation oncologists
- Medical physicists
- Radiation oncology medical and physics residents
- Recognize and understand the importance of the multidisciplinary approach to the care of my cancer patients.
- Assess emerging data and technical information regarding changes and progress in the radio-therapeutic management of all forms of cancers from typical to atypical.
- Assess the significance of new radiation approaches and technologies for the treatment of variouscancer patients based on research and clinical outcomes.
- Determine the optimal radio-therapeutic techniques for individual cancer patients with the utilization of new technologies.
- Improve the quality and safety of patient radiation therapy treatments, while utilizing available tools and data and optimizing mortality rates and treatment outcomes.
- Identify non-radiation approached to the cancer patient
- Identify concurrent therapies to be used with radiation to achieve the best outcome for the cancer patient.
|Christopher Schultz, MD||Elekta, Philips, Accuray, Siemens||Speaker|
|Beth Erickson, MD||Elekta, Philips, Accuray, Siemens||Speaker|
|Eric Paulson, PhD||Elekta, Philips, Accuray, Siemens||Research/ Speaker|
|Jared Robbins, MD||Elekta, Philips, Accuray, Siemens||Speaker|
|William Hall, MD||Elekta, Philips, Accuray, Siemens||Research/ Speaker|
|Allen Li, PhD||Elekta, Philips, Accuray, Siemens||Research/ Speaker|